webinar: advancing dyne-251 - an investigational medicine for duchenne to deliver for patients
Published 2 months ago • 464 plays • Length 1:00:59Download video MP4
Download video MP3
Similar videos
-
53:00
webinar: dyne therapeutics — advancing dyne-251, an investigational medicine for dmd [jan 2024]
-
48:50
webinar: dyne therapeutics — advancing force in the pursuit of transformative therapies (april 2023)
-
42:18
webinar: dyne therapeutics update on dyne-251 (july 2022)
-
24:18
community webinar: dyne-251 potentially transformative therapy for duchenne
-
56:21
[webinar] domagrozumab as a potential treatment for duchenne - may 2019
-
1:04:24
webinar: viltepso - a treatment option for patients amenable to exon 53 skipping (april 2021)
-
37:27
webinar: viltepso, an fda-approved treatment for patients amenable to exon 53 skipping (march 2023)
-
1:06:22
webinar: srp-9001 data update from studies 101, 102, and 103 (august 2022)
-
53:56
[webinar] italfarmaco provides givinostat update - january 2018
-
58:48
webinar: transforming the treatment paradigm with dyne therapeutics (march 31, 2021)
-
58:18
[webinar] summit's utrophin modulation program - january 2017
-
1:08:13
[webinar] gene therapy for duchenne - august 2017
-
54:42
webinar: ataluren update with ptc
-
1:13:49
hope-duchenne trial - capricor therapeutics [january 2016 webinar]
-
1:09:52
webinar: srp-9001 micro-dystrophin gene therapy clinical update (october 2021)
-
33:36
community webinar: transforming the treatment paradigm for duchenne
-
1:09:05
[webinar] hope-2 duchenne clinical trial – capricor – july 2018
-
37:14
cureduchenne and dyne therapeutics: dyne-251 transforming the treatment paradigm for dmd